Current treatment of chronic hepatitis B: Clinical aspects and future directions

Area of Science:

• Hepatology
• Virology
• Public Health

Background:

• Hepatitis B virus (HBV) infection is a significant global health concern.
• HBV infection can lead to severe liver conditions like cirrhosis and cancer, particularly in the Asia-Pacific region.
• Current treatments for HBV infection are limited, necessitating clear clinical guidelines.

Purpose of the Study:

• To review and compare international guidelines for Hepatitis B prevention and treatment.
• To clarify treatment indications for the general population and specific patient groups.
• To discuss controversial aspects and future perspectives in HBV management.

Main Methods:

• Comparative analysis of major international HBV treatment guidelines (Chinese, AASLD, EASL, APASL).
• Systematic review of recommendations regarding patient selection for therapy.
• Discussion of clinical practice challenges and emerging trends in HBV management.

Main Results:

• Guidelines vary on specific treatment thresholds and patient populations.
• Key differences exist in managing chronic HBV infection across different international recommendations.
• Several controversial issues require further clarification for optimal clinical practice.

Conclusions:

• International guidelines provide a framework for HBV management but require ongoing updates.
• Addressing treatment controversies and specific population needs is crucial for improving patient outcomes.
• Further research and consensus are needed to optimize global HBV treatment strategies.